CA3012383C - Biosynthesis of cannabinoids - Google Patents

Biosynthesis of cannabinoids Download PDF

Info

Publication number
CA3012383C
CA3012383C CA3012383A CA3012383A CA3012383C CA 3012383 C CA3012383 C CA 3012383C CA 3012383 A CA3012383 A CA 3012383A CA 3012383 A CA3012383 A CA 3012383A CA 3012383 C CA3012383 C CA 3012383C
Authority
CA
Canada
Prior art keywords
cannabinoid
synthase
reaction mixture
thca
cio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3012383A
Other languages
English (en)
French (fr)
Other versions
CA3012383A1 (en
Inventor
Robert WINNICKI
Marc DONSKY
Richard PEET
Mingyang Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teewinot Technologies Ltd
Original Assignee
Teewinot Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teewinot Technologies Ltd filed Critical Teewinot Technologies Ltd
Publication of CA3012383A1 publication Critical patent/CA3012383A1/en
Application granted granted Critical
Publication of CA3012383C publication Critical patent/CA3012383C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H6/00—Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
    • A01H6/28—Cannabaceae, e.g. cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M21/00—Bioreactors or fermenters specially adapted for specific uses
    • C12M21/18—Apparatus specially designed for the use of free, immobilized or carrier-bound enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/30—Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/48—Automatic or computerized control
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/24—Preparation of oxygen-containing organic compounds containing a carbonyl group
    • C12P7/26—Ketones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/42—Hydroxy-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y121/00—Oxidoreductases acting on X-H and Y-H to form an X-Y bond (1.21)
    • C12Y121/03—Oxidoreductases acting on X-H and Y-H to form an X-Y bond (1.21) with oxygen as acceptor (1.21.3)
    • C12Y121/03007—Tetrahydrocannabinolic acid synthase (1.21.3.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y121/00—Oxidoreductases acting on X-H and Y-H to form an X-Y bond (1.21)
    • C12Y121/03—Oxidoreductases acting on X-H and Y-H to form an X-Y bond (1.21) with oxygen as acceptor (1.21.3)
    • C12Y121/03008—Cannabidiolic acid synthase (1.21.3.8)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y203/00—Acyltransferases (2.3)
    • C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C12Y203/01206—3,5,7-Trioxododecanoyl-CoA synthase (2.3.1.206)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y205/00—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
    • C12Y205/01—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
    • C12Y205/01102—Geranyl-pyrophosphate—olivetolic acid geranyltransferase (2.5.1.102)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Sustainable Development (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Computer Hardware Design (AREA)
  • Environmental Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Botany (AREA)
  • Physiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Enzymes And Modification Thereof (AREA)
CA3012383A 2013-02-28 2014-02-27 Biosynthesis of cannabinoids Active CA3012383C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361770766P 2013-02-28 2013-02-28
US61/770,766 2013-02-28
CA2902452A CA2902452C (en) 2013-02-28 2014-02-27 Chemical engineering processes and apparatus for the synthesis of compounds

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2902452A Division CA2902452C (en) 2013-02-28 2014-02-27 Chemical engineering processes and apparatus for the synthesis of compounds

Publications (2)

Publication Number Publication Date
CA3012383A1 CA3012383A1 (en) 2014-09-04
CA3012383C true CA3012383C (en) 2021-03-02

Family

ID=51428796

Family Applications (2)

Application Number Title Priority Date Filing Date
CA3012383A Active CA3012383C (en) 2013-02-28 2014-02-27 Biosynthesis of cannabinoids
CA2902452A Active CA2902452C (en) 2013-02-28 2014-02-27 Chemical engineering processes and apparatus for the synthesis of compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2902452A Active CA2902452C (en) 2013-02-28 2014-02-27 Chemical engineering processes and apparatus for the synthesis of compounds

Country Status (9)

Country Link
US (8) US9359625B2 (enExample)
EP (1) EP2961402B1 (enExample)
JP (3) JP6581509B2 (enExample)
CN (1) CN105555265A (enExample)
AU (2) AU2014223458A1 (enExample)
BR (1) BR112015020332A2 (enExample)
CA (2) CA3012383C (enExample)
IL (1) IL240830B (enExample)
WO (1) WO2014134281A1 (enExample)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6581509B2 (ja) 2013-02-28 2019-09-25 ティーウィノット テクノロジーズ リミテッド 化合物を合成する化学工学プロセス及び装置
US11293038B2 (en) 2014-07-14 2022-04-05 Librede Inc. Production of cannabinoids in yeast
US9822384B2 (en) 2014-07-14 2017-11-21 Librede Inc. Production of cannabinoids in yeast
AU2015308136B2 (en) * 2014-08-25 2020-07-09 Teewinot Technologies Limited Apparatus and methods for the simultaneous production of cannabinoid compounds
BR122021018502B1 (pt) 2014-10-21 2022-05-03 United Cannabis Corp Formulação de canabinoide líquida
US10350165B2 (en) 2014-12-12 2019-07-16 Ojai Energetics Pbc Methods and systems for forming stable droplets
MX395015B (es) 2014-12-12 2025-03-24 Ojai Energetics Pbc Composiciones microencapsuladas de cannabinoides
WO2017175064A1 (en) * 2016-04-04 2017-10-12 Full Spectrum Laboratories Ltd Bioenzymatic synthesis of tetrahydrocannabivarin (thc-v), cannabinol (cbn), and cannabivarin (cbv) and their use as therapeutic agents
EP3442953A1 (en) * 2016-04-15 2019-02-20 Teewinot Technologies Limited Biosynthesis of cannabinoid prodrugs
US10588974B2 (en) 2016-04-22 2020-03-17 Receptor Holdings, Inc. Fast-acting plant-based medicinal compounds and nutritional supplements
EP3471745B1 (en) * 2016-06-15 2025-03-26 Ojai Energetics PBC Compositions for reducing oxidative stress
EP3541772A1 (en) * 2016-11-15 2019-09-25 Teewinot Technologies Limited Bio-stable cannabinoid compounds and methods for enhancing their physiological concentration
EA201892396A1 (ru) 2016-12-02 2019-04-30 Ресептор Лайф Сайенсиз, Инк. Быстродействующие растительные лекарственные соединения и биологически активные добавки
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
AU2018220470B2 (en) 2017-02-17 2022-02-24 Hyasynth Biologicals Inc. Method and cell line for production of polyketides in yeast
WO2018176055A2 (en) 2017-03-24 2018-09-27 Trait Biosciences, Inc. High level in vivo biosynthesis and isolation of water-soluble cannabinoids in plant systems
AU2018260710B2 (en) * 2017-04-26 2022-07-21 Teewinot Technologies Limited Apparatus, methods and composition for synthesis of cannabinoid compounds
EP3615667B1 (en) * 2017-04-27 2021-08-11 The Regents of The University of California Microorganisms and methods for producing cannabinoids and cannabinoid derivatives
US11905543B2 (en) 2017-07-11 2024-02-20 Trait Biosceinces, Inc. In vivo generation of water-soluble acetylated cannabinoid glycoside compounds in plant cell suspension cultures
EP3730145A1 (en) 2017-07-11 2020-10-28 Trait Biosciences, Inc. Generation of water-soluble cannabinoid compounds in yeast and plant cell suspension cultures and compositions of matter
US11946059B2 (en) 2017-07-11 2024-04-02 Trait Biosciences, Inc. In vivo generation of water-soluble cannabinoids in plant cell suspension cultures
EP3652327A4 (en) 2017-07-12 2021-04-21 Biomedican, Inc. Production of cannabinoids in yeast
SG11202001924XA (en) 2017-09-05 2020-04-29 Inmed Pharmaceuticals Inc Metabolic engineering of e. coli for the biosynthesis of cannabinoid products
EP3691442A4 (en) 2017-10-03 2021-07-07 The Regents of the University of Colorado PROCESS FOR DIFFERENTIATING CANNABIS PLANT CULTIVARS BASED ON CANNABINOID SYNTHASE PARALOGUES
KR102398709B1 (ko) 2017-10-20 2022-05-16 제이에프이 스틸 가부시키가이샤 고강도 강판 및 그 제조 방법
EP3745884A1 (en) 2018-01-31 2020-12-09 Canopy Holdings, Llc Hemp powder
WO2019209885A2 (en) 2018-04-23 2019-10-31 Renew Biopharma, Inc. Enzyme engineering to alter the functional repertoire of cannabinoid synthases
US10801049B2 (en) 2018-06-14 2020-10-13 Syntiva Therapeutics, Inc. Genetically engineered microorganisms and processes for the production of cannabinoids from a carbon source precursor
US11040932B2 (en) 2018-10-10 2021-06-22 Treehouse Biotech, Inc. Synthesis of cannabigerol
EP3873459A1 (en) 2018-10-31 2021-09-08 Enantia, S.L. Solid compositions of cocrystals of cannabinoids
US12303487B2 (en) 2018-11-19 2025-05-20 Spoke Sciences, Inc. N-acylated fatty amino acids to reduce absorption variability in cannabinoid based compositions
CN109734591A (zh) * 2018-12-26 2019-05-10 江苏暨明医药科技有限公司 一种大麻二酚中间体及其制备方法与及应用
EP3931330A4 (en) 2019-02-25 2023-03-15 Ginkgo Bioworks, Inc. BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS
CA3129535A1 (en) 2019-03-07 2020-09-10 Oludare ODUMOSU Formulations for treating cluster symptoms associated with autism spectrum disorder
SG11202111975UA (en) * 2019-05-22 2021-11-29 Demetrix Inc Optimized cannabinoid synthase polypeptides
EP4067330B1 (en) 2019-06-11 2024-03-20 Symrise AG Cosmetic use of cannabigerol
US10717056B1 (en) 2019-09-09 2020-07-21 Michael Cem Gokay Method and apparatus for purification of cannabinoid extracts
KR20220110476A (ko) * 2019-10-08 2022-08-08 베서, 파마 엘엘씨 칸나비노이드 및 칸나비노이드산의 제조공정
WO2021071438A1 (en) * 2019-10-11 2021-04-15 National University Of Singapore Biosynthesis of cannabinoids from cannabigerolic acid using novel cannabinoid synthases
AU2020364933A1 (en) * 2019-10-11 2022-04-21 National University Of Singapore Sustainable production of cannabinoids from simple precursor feedstocks using
WO2021211611A1 (en) 2020-04-14 2021-10-21 Genomatica, Inc. Cannabinoid synthase variants and methods for their use
WO2021226711A1 (en) * 2020-05-12 2021-11-18 Canopy Growth Corporation Methods of synthesizing cannabigergol, cannabigerolic acid, and analogs thereof
CA3132439A1 (en) * 2020-05-12 2021-11-12 Canopy Growth Corporation Methods of synthesizing cannabigergol, cannabigerolic acid, and analogs thereof
CA3203361A1 (en) 2020-12-31 2022-07-07 Parker BERLING Compositions comprising cannabis and mushroom extracts, and uses thereof
WO2022204207A1 (en) * 2021-03-22 2022-09-29 Cb Therapeutics, Inc. Biosynthetic methods for the modification of cannabinoids
US20240368643A1 (en) * 2021-06-04 2024-11-07 Amyris, Inc. Methods of purifying cannabinoids
WO2023043946A2 (en) * 2021-09-15 2023-03-23 The Regents Of The University Of California Cannabinoid production in bacteria

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5086646A (en) 1989-09-12 1992-02-11 Jamison Dale E Apparatus and method for analyzing well fluid sag
US5290701A (en) * 1991-08-28 1994-03-01 Wilkins Judd R Microbial detection system and process
US5302525A (en) * 1992-11-23 1994-04-12 National Research Council Of Canada Methylobacterium extorquwns microorganism useful for the preparation of poly-β-hydroxybutyric acid polymers
US7530461B2 (en) * 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
US6113940A (en) 1997-03-03 2000-09-05 Brooke; Lawrence L. Cannabinoid patch and method for cannabis transdermal delivery
JP2000078979A (ja) 1998-09-04 2000-03-21 Taisho Pharmaceut Co Ltd テトラヒドロカンナビノール酸シンターゼ遺伝子
AR022383A1 (es) * 1998-09-18 2002-09-04 Univ Kentucky Res Found Sintasas
US6403126B1 (en) 1999-05-26 2002-06-11 Websar Innovations Inc. Cannabinoid extraction method
US6949582B1 (en) 1999-05-27 2005-09-27 Wallace Walter H Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment
JP2001029082A (ja) * 1999-07-22 2001-02-06 Yukihiro Masayama カンナビジオール酸シンターゼをコードするｄｎａ
US6730330B2 (en) 2001-02-14 2004-05-04 Gw Pharma Limited Pharmaceutical formulations
US6946150B2 (en) 2002-08-14 2005-09-20 Gw Pharma Limited Pharmaceutical formulation
AU2003263895A1 (en) 2002-08-16 2004-03-03 Immugen Pharmaceuticals, Inc. Contraceptive methods and formulations
GB0222077D0 (en) 2002-09-23 2002-10-30 Gw Pharma Ltd Methods of preparing cannabinoids from plant material
DE10335130A1 (de) * 2003-07-31 2005-02-24 Blue Membranes Gmbh Immobilisierung von Katalysatoren auf porösen Körpern auf Kohlenstoffbasis
GB2418612A (en) 2004-10-01 2006-04-05 Gw Pharma Ltd Inhibition of tumour cell migration with cannabinoids
KR20070101359A (ko) * 2005-01-28 2007-10-16 더 솔크 인스티튜트 포 바이올로지칼 스터디즈 신규한 방향족 프레닐트랜스퍼라제, 이것을 코드화한 핵산및 그의 용도
KR20070118157A (ko) 2005-04-01 2007-12-13 바스프 악티엔게젤샤프트 해유화제로서의 단백질의 용도
US20090197308A1 (en) * 2005-05-12 2009-08-06 Jian Liu Enzymatic synthesis of sulfated polysaccharides
JP2007020466A (ja) 2005-07-15 2007-02-01 Institute Of Physical & Chemical Research 大麻ＣａｎｎａｂｉｓｓａｔｉｖａＬ．の識別方法
DK1903866T3 (en) 2005-11-07 2016-07-25 Murty Pharmaceuticals Inc Improved release of tetrahydrocannabinol
US9265724B2 (en) 2005-11-07 2016-02-23 Ram B. Murty Oral dosage form of tetrahydrocannabinol and a method of avoiding and/or suppressing hepatic first pass metabolism via targeted chylomicron/lipoprotein delivery
GB2434312B (en) 2006-01-18 2011-06-29 Gw Pharma Ltd Cannabinoid-containing plant extracts as neuroprotective agents
GB2450493A (en) * 2007-06-25 2008-12-31 Gw Pharma Ltd Cannabigerol for use in treatment of diseases benefiting from agonism of CB1 and CB2 cannabinoid receptors
US20110091930A1 (en) 2008-02-14 2011-04-21 The General Hospital Corporation Well-based flow system for cell culture
GB2459125B (en) 2008-04-10 2013-01-02 Gw Pharma Ltd Method if extracting cannabichromene and its acid from Cannabis sativa plant material
US9921576B2 (en) * 2008-05-05 2018-03-20 Finesse Solutions, Inc. Virtual transmitter for bioreactor automation system
EP2293677B1 (en) * 2008-06-13 2017-11-15 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
KR101292379B1 (ko) 2009-04-08 2013-08-09 브리스톨-마이어스 스큅 컴퍼니 Ｐｄｈ 및 ｆｄｈ 효소를 발현하는 유전적으로 안정한 플라스미드
DE102009019322A1 (de) * 2009-04-30 2010-11-11 The Health Concept Gmbh Verfahren zur Herstellung von Synthetischen Cannabinoiden
US20120117686A1 (en) 2009-05-04 2012-05-10 The Regentsof The University Of California Stress-tolerant plants expressing mannosylglycerate-producing enzymes
US20110003703A1 (en) * 2009-07-01 2011-01-06 Charles Ma Nucleic Acid Hybridization and Detection Using Enzymatic Reactions on a Microarray
US8884100B2 (en) 2009-08-12 2014-11-11 National Research Council Of Canada Aromatic prenyltransferase from Cannabis
HUE033099T2 (en) * 2009-12-01 2017-11-28 Abbvie Inc Novel tricyclic compounds
GB2478595B (en) 2010-03-12 2018-04-04 Gw Pharma Ltd Phytocannabinoids in the treatment of glioma
WO2011127589A1 (en) * 2010-04-15 2011-10-20 National Research Council Of Canada Genes and proteins for aromatic polyketide synthesis
JP5751661B2 (ja) 2010-11-02 2015-07-22 国立研究開発法人農業・食品産業技術総合研究機構 デキストラングルカナーゼ
JP2012130294A (ja) 2010-12-22 2012-07-12 Tosoh Corp 抗体結合タンパク質およびその製造方法
US8808734B2 (en) * 2011-07-11 2014-08-19 Full Spectrum Laboratories Limited Cannabinoid formulations
DK2732037T3 (en) 2011-07-13 2018-02-26 Nat Res Council Canada GENES AND PROTEINS FOR ALKANOYL-COA SYNTHESIS
US20140057251A1 (en) 2011-08-18 2014-02-27 Medicinal Genomics Corporation Cannabis Genomes and Uses Thereof
GB2494461A (en) 2011-09-12 2013-03-13 Gw Pharma Ltd Phytocannabinoids for use in the treatment of invasive cancers or metastases
GB2495118B (en) 2011-09-29 2016-05-18 Otsuka Pharma Co Ltd A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
GB2496688B (en) 2011-11-21 2016-06-29 Gw Pharma Ltd Tetrahydrocannabivarin for use in the treatment of intestinal inflammatory diseases
CA2868447C (en) 2012-03-30 2020-09-15 The Scripps Research Institute Cyclic prodrugs of duocarmycin analogs
CA2872528C (en) 2012-05-03 2021-01-05 Echo Pharmaceuticals B.V. Cannabis plant isolate comprising .delta.9-tetrahydrocannabinol and a method for preparing such an isolate
JP6581509B2 (ja) 2013-02-28 2019-09-25 ティーウィノット テクノロジーズ リミテッド 化合物を合成する化学工学プロセス及び装置
WO2014145490A2 (en) 2013-03-15 2014-09-18 Biotech Institute, Llc Breeding, production, processing and use of specialty cannabis
ES2525137B1 (es) 2013-06-13 2016-01-18 Servicio Andaluz De Salud Agentes para tratar el mieloma múltiple
WO2015003012A2 (en) 2013-07-01 2015-01-08 Olivier Berteau Distributed perfusion bioreactor system for continuous culture of biological cells
US9326967B2 (en) 2013-08-22 2016-05-03 Stephen C. Perry Vaporizable cannabinoid compositions
WO2015142500A2 (en) 2014-03-21 2015-09-24 Bodybio Inc. Compositions and methods for treating addiction
CA2956919C (en) * 2014-07-21 2022-07-19 Glia, Llc Method for treating radiotherapy- and chemotherapy-associated cognitive or emotional impairment with cannabinoids
AU2015308136B2 (en) 2014-08-25 2020-07-09 Teewinot Technologies Limited Apparatus and methods for the simultaneous production of cannabinoid compounds
AU2018260710B2 (en) * 2017-04-26 2022-07-21 Teewinot Technologies Limited Apparatus, methods and composition for synthesis of cannabinoid compounds

Also Published As

Publication number Publication date
US10472652B2 (en) 2019-11-12
CA2902452C (en) 2018-09-04
US9526715B1 (en) 2016-12-27
AU2018228329A1 (en) 2018-09-27
CA2902452A1 (en) 2014-09-04
US10214753B2 (en) 2019-02-26
US20200048664A1 (en) 2020-02-13
JP2018086012A (ja) 2018-06-07
US9861609B2 (en) 2018-01-09
EP2961402A4 (en) 2016-11-23
WO2014134281A1 (en) 2014-09-04
EP2961402A1 (en) 2016-01-06
JP6724052B2 (ja) 2020-07-15
CN105555265A (zh) 2016-05-04
JP2016509842A (ja) 2016-04-04
US9359625B2 (en) 2016-06-07
EP2961402B1 (en) 2024-10-02
US20180230499A1 (en) 2018-08-16
IL240830A0 (en) 2015-10-29
AU2014223458A1 (en) 2015-10-15
US20170159080A1 (en) 2017-06-08
BR112015020332A2 (pt) 2017-07-18
US20160355854A1 (en) 2016-12-08
US20170152530A1 (en) 2017-06-01
US20170247650A1 (en) 2017-08-31
US20160355853A1 (en) 2016-12-08
IL240830B (en) 2022-08-01
JP2020022507A (ja) 2020-02-13
CA3012383A1 (en) 2014-09-04
US10081818B2 (en) 2018-09-25
JP6581509B2 (ja) 2019-09-25
US20150361469A1 (en) 2015-12-17

Similar Documents

Publication Publication Date Title
CA3012383C (en) Biosynthesis of cannabinoids
JP6622793B2 (ja) カンナビノイド化合物を同時作製する装置及び方法

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20180724